Effects of L-carnitine on kidney histopathology, plasma and tissue total sialic acid, malondialdehyde and glutathione concentrations in response to gentamicin administration in Balb/C mice

Revue de Medecine Veterinaire

Volumn 157, Issue 4, 2006, Pages 179-184

  Kart, A ^a   Yapar, K ^a   Karapehlivan, M ^a   Tunca, R ^a   Ogun, M ^a   Citil, M ^a  

^a KAFKAS UNIVERSITY   (Turkey)

Author keywords

Gentamicin; L carnitine; Nephrotoxicity; Oxidative Stress; Sialic acid

Indexed keywords

EID: 33646784721     PISSN: 00351555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. - ALI B.H., BASHIR A.K.: Effect of superoxide dismutase treatment on gentamicin nephrotoxicity in rats. Gen. Pharmac., 1996, 27, 349-353.
2. - ANDRIEU-ABADIE N., JAFFREZOU J.P., HATEM S., LAURENT G., LEVADE T., MERCADIER JJ.: L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation. FASEB J., 1999, 13, 1501-1510.
3. - ARDUINI A.: Carnitine and its acyl esters as secondary antioxidants? Am. Heart J., 1992, 123, 1726-1727.
4. - ASHRAF V., FRANCO G., SYED I., ZBIGNIEW B., SYED A.: The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction. Ann. N Y Acad. Sci., 2002, 965, 225-232.
5. - BEUCAIRE G.: Does once-daily dosing prevent nephrotoxicity in all aminoglycosides equally, Clin. Microbiol. Infect., 2000, 6, 355-360.
6. - BEUTLER E., DURAN O., KELLEY B.M.: Improved method for determination of blood glutathion. J. Lab. Clin. Med., 1963, 28, 882-888.
7. - BRASS E.M.: Supplemental carnitine and exercise. Am. J. Clin. Nutr., 2000, 72 (suppl), 618-23.
8. - DE ZWART L.L., MEERMAN J.H.N., COMMANDEUR J.N.M., VERMEULEN N.P.E.: Biomarkers of free radical damage applications in experimental animals and in humans. Free Radie. Biol. Med., 1999, 26, 202-226.
9. - DI GIACOMO C., LATTERI F., FICHERA C., SORRENTI V., CAMPISI A., CASTORINA C., RUSSO A., PINTURA R., VANELLA A.: Effect of acetyl L- carnitine on lipid peroxidation and xanthine oxidase activity in rat skeletal muscle. Neurochem. Res., 1993, 18, 1157-1162.
10. - DIPLOCK A.T.: Antioxidants and free radical scavengers; in Rice-Evans CA, Burdon RH (eds): Free radical damage and its Control. Amsterdam, Elsevier, 1994, 113-130.
11. - DRÖGE W.: Free Radicals in the Physiological Control of Cell Function. Physiol. Rev., 2002, 82, 47-95.
12. - ERDEM A., GÜNDOǦAN N.Ü., USUBÜTÜN A., KÜÇÜKALI T., KILIN K.: The antioxidant action of N-acetylcysteine on gentamicin-induced acute tubular necrosis in rats. Gazi Med. J., 1999, 10, 21-28.
13. - GALLE J.: Oxidative stress in chronic renal failure. Nephrol. Dial. Transplant., 2001, 16, 2135-2137.
14. - HAGEN T.M., WEHR C.M., AMES B.N.: Mitochondrial decay in ageing. Reversal through supplementation of acetyl-L-carnitine and N-tetri-butyle-alpha- phenyl-nitrone. Ann. NY Acad. Sci., 1998, 854, 214-223.
15. - KALAISELVI T., PANNEERSELVAM C.: Effect of L-carnitine on the status of lipid peroxidation and antioxidants in aging rats. J. Nutr. Biochem., 1998, 9, 575-581.
16. +-ATPase glutathione-s-transferase and multiple unit activity and reduces lipid peroxidation and lipofuscin concentration in aged rat brain regions. Neurosci. Lett., 2001, 301, 1-4.
17. - KELLY G.S.: L-Carnitine: Therapeutic applications of a conditionally-essential amino acid. Altern. Med. Rev., 1998, 3, 345-360.
18. - LINDBERG G., EKLUND G.A., GULLBERG B., RASTAM L.: Serum sialic acid concentration and cardiovascular mortality. Br. Med. J., 1991, 302, 143-146.
19. - MALDANADO P.D., BARRERA D., RIVERO I., MATA R., MEDINA-CAMPOS O.N., HERNANDEZ-PANDO R., PEDRAZA-CHAVERRO J.: Antioxidant S- allylcysteine prevents gentamicin induced oxidative stress and renal damage. Free Radic. Biol. Med., 2003, 35, 317-324.
20. - MINGEOT-LECLERCQ M., TULKENS P.M.: Aminoglycosides: Nephrotoxicity. Antimicrob. Agents Chemother., 1999, 43, 1003-1012.
21. - MOUEDDEN M.E., LAURENT G., MINGEOT-LECLERCQ M.P., TAPER H.S., CUMPS J., TULKENS P.M.: Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides. Antimicrob. Agents Chemother., 2000, 44(3), 665-675.
22. - OZTURK HS, KAVUTCU M, KACMAZ M, CANBOLAT O, DURAKI.: The effects of gentamicin on the activities of glutathione peroxidase and superoxide dismutase enzymes and malondialdehyde levels in heart tissues of guinea pigs. Curr. Med. Res. Opin., 1997, 14 (1), 47-52.
23. - PALLOR M.S., HOLDAL J.R., FERRIS T.F.: Oxygen free radicals in ischemic acute renal failure in the rat. J. Clin. Invest., 1984, 74, 1156-1164.
24. - PEDRAZA-CHAVERRÍ J., MALDANADO P.D., BARRERA D., CERON A., MEDINA-CAMPOS O.N., HERNANDEZ-PANDO R.: Protective effect of diallyl sulfide on oxidative stress and nephrotoxicity induced by gentamicin in rats. Mol. Cell. Biochem., 2003, 254, 125-130.
25. - RANI P.J., PANNEERSELVAM C.: Carnitine as a free radical scavenger in aging. Exp. Gerontol., 2001, 36, 1713-26.
26. - RANI P.J., PANNEERSELVAM C.: Effect of L-carnitine on brain lipid peroxidation and antioxidant enzymes in old rats. J. Gerontol. A. Biol. Sci. Med. Sci., 2002, 57, 134-137.
27. - RAMSAMMY L.S., JOSEPOVITZ C., LANE B., KALOYANIDES G.J.: Effect of gentamicin on phospholipid metabolism in cultured rabbit proximal tubular cells. Am. J. Physiol., 1989, 256, 204-213.
28. - SENER G., PASKALOGLU K., SATIROGLU H., ALICAN I., KACMAZ A., SAKARCAN A.: L-carnitine ameliorates oxidative damage due to chronic renal failure in rats. J. Cardiovasc. Pharmacol, 2004, 43, 698-705.
29. - SHAMBERGER R.J.: Serum sialic acid in normals and in cancer patients. J. Clin. Chem. Clin. Biochem., 1984, 22, 647-51.
30. - SILLANAUKEE P., PÖNNIÖ M., JÄÄSKELÄINEN I.P.: Occurrence of sialic acids in healthy humans and different disorders. Eur. J. Clin. Nutr., 1999, 29, 413-425.
31. - SILVER H.K.B., MURRAY R.N., WORTH A.J., SALINAS F.A., SPINELLI J.J.: Prediction of malignant melanoma recurrence by serum N-acetylneuraminic acid. Int. J. Cancer., 1983, 31, 39-43.
32. - SIMMONS C.F. JR., BOGUSKY R.T., HUMES H.D.: Inhibitory effects of gentamicin on renal mitochondrial oxidative phosphorylation. J. Pharmacol. Exp. Ther., 1980, 214, 709-15.
33. - SUNDIN D.P., SANDOVAL R., MOLITORIS B.A.: Gentamicin inhibits renal protein and phospholipid metabolism in rats: implications involving intracellular trafficking. J. Am. Soc. Nephrol., 2001, 12, 114-123.
34. - SYDOW G.: A simplified quick method for determination of sialic acid in serum. Biomed. Biochem. Acta., 1985, 44, 1721-1723.
35. - SZILAGYI M.: L-carnitine as essential methylated compound in animal metabolism. An overview., Acta Biol. Hung., 1998, 49, 209-218.
36. - TYLICKI L., RUTKOWSKI B., HÖRL W.H.: Antioxidants: a possible role in kidney protection. Kidney Blood Press. Res., 2003, 26, 303-314.
37. - WALKER P.D., SHAH S.V.: Gentamicin enhanced production of hydrogen peroxide by renal cortical mitochondria. Am. J. Physiol., 1987, 253, 495-499.
38. - WALKER P.D., SHAH S.V.: Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. J. Clin. Invest., 1988, 81, 334-341.
39. - WANG B., BRAND-MILLER J.: The role and potential of sialic acid in human nutrition. Eur. J. Clin. Nutr., 2003, 57, 1351-1369.
40. - WANG A.M., SHA S.H., LESNIAK W., SCHACHT J.: Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo., Antimicrob. Agents Chemother., 2003, 47, 1836-1841.
41. - WU G., FANG Y., YANG S., LUPTON JR., TURNER ND.: Glutathione metabolism and its implications for health. J. Nutr., 2004, 134, 489-492.
42. - YOSHOIKO T., KAWADA K., SHIMADA T.: Lipid peroxidation in maternal and cord blood and protective mechanism against actived-oxygen toxicity in the blood. Am. J. Obstet. Gynecol., 1979, 135, 372-376.